Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
about
Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver GraftsHepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-AnalysisThe Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-AnalysisHepatitis C: Treatment of difficult to treat patientsReview of the evidence: prevalence of medical conditions in the United States population with serious mental illnessAACR Cancer Progress Report 2014Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in EuropeGender-based disparities in access to and outcomes of liver transplantationTreatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis CElevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV InfectionResults of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypesAnnual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.HCV screening in a cohort of HIV infected and uninfected homeless and marginally housed women in San Francisco, CaliforniaLong-term outcomes of heart transplant recipients with hepatitis C positivity: the data from the U.S. transplant registry.Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration.Preference, acceptability and implications of the rapid hepatitis C screening test among high-risk young people who inject drugs.Age, hepatitis C virus infection, and the risk of cancer: Unlocking a complex puzzle of interactions.Oral surgery in a patient with cirrhosis and thrombocytopenia: a case report.Clinical efficacy and tolerability of direct-acting antivirals in elderly patients with chronic hepatitis C.Factors associated with success of telaprevir- and boceprevir-based triple therapy for hepatitis C virus infection.Hepatitis C in a New Era: A Review of Current TherapiesIdentifying and characterizing hepatitis C virus hotspots in Massachusetts: a spatial epidemiological approach.Sofosbuvir-based Regimens with Task Shifting Is Cost-effective in Expanding Hepatitis C Treatment Access in the United States.Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.The risk of HCV infection among health-care workers and its association with extrahepatic manifestations (Review).Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010Hepatitis C Virus and Nonliver Solid Cancers: Is There an Association between HCV and Cancers of the Pancreas, Thyroid, Kidney, Oral Cavity, Breast, Lung, and Gastrointestinal Tract?Impact of an Electronic Medical Record-Based System to Promote Human Immunodeficiency Virus/Hepatitis C Virus Screening in Public Hospital Primary Care ClinicsAlcohol Consumption in Concomitant Liver Disease: How Much is Too Much?Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Evaluating a Collaborative Approach to Improve Prior Authorization Efficiency in the Treatment of Hepatitis C VirusHistorical trends and projected hospital admissions for chronic hepatitis C infection in Canada: a birth cohort analysis.Duplicate hepatitis C antibody testing in New York City, 2006-2010.Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological responseSexually transmitted diseases treatment guidelines, 2015.Toward a more accurate estimate of the prevalence of hepatitis C in the United States.Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States.Systematic review: current concepts and challenges for the direct-acting antiviral era in hepatitis C cirrhosis.
P2860
Q21131741-23646985-8E26-4DDA-A22B-EAF9732590F2Q26768490-C98F990D-4C20-4992-8320-B1E9384582EBQ26795711-D02DA0F1-1F33-44EA-BF28-CDEC9BADB7E4Q26798465-73657A0F-0D19-45EA-8502-7D441991F9ADQ26849474-482CD38E-A564-498E-94C9-59385EFF6279Q27346723-D88DDFA8-4639-48D7-838C-0BA6E5167F95Q28079580-2F3F5989-6624-42A7-87B5-D6D8525336A0Q28083778-F6831D3E-760F-4978-9C62-206AB20AE5BBQ28552691-33D09A1C-5E18-4779-A55D-EF98D79FEC0FQ28553005-3B682944-AEF1-40A2-89FF-34AE8255346CQ30151392-17AD3AB1-3848-4C16-83D3-B6DD7D870CC7Q30245058-4D71B586-9CF2-403D-ABF9-4C68913FEAE6Q30746254-87C3F98F-A7AF-4D92-AE57-A409DA74511FQ30837913-341EDCB7-4893-4A31-97D7-005826BF89F2Q31136569-2EEB6E0A-642C-4143-826C-AF1921DF5EB0Q31143582-3BB322C1-0936-4DD6-A858-25B355520451Q31168171-881A1C10-6CA5-43F4-A1E0-E993C661D35AQ33364626-88C7CBE8-6FFC-4193-AB3F-B3AB735F4636Q33428044-7EC5500D-FDFD-49EC-AFAF-B8BC98265FC2Q33440436-71A85254-BF22-403C-8B8C-68BF64A7D096Q33576531-EFB02BE1-DE97-407F-9A99-4473F24CDAEAQ33585021-A0148A00-D54A-40EB-978C-CE275D6B73CBQ33587555-3DAA0EE5-ACF2-441D-8E93-A270199310DDQ33621614-C7306573-0DA2-4450-8855-622CB6B8816BQ33629561-763C8B74-DD26-439F-BE42-482A9D74305DQ33643082-449859DE-B520-4D33-91CA-8B38719A7E4FQ33673394-8DB841C0-CEB3-4720-9E44-2A4740D4076AQ33696050-B02B898E-59DD-4E45-8EDA-D8F718E6D41AQ33696523-F271D6E7-0E44-495A-982A-B3D473B1C854Q33745336-D3D5B03A-EC3A-46E6-BEAF-9655EB893F60Q33840930-16E89EE2-ABFE-4C70-9603-CCD3A03D4864Q33853664-A3C0FE24-107C-4328-9A4F-090D553398FDQ33879348-DD2E1497-8E15-4611-99F3-9C4499F0E163Q34280145-F993C0E4-E6FC-4633-BA8E-C57C9031DF39Q34296321-3BB09646-108C-40B8-B360-70437B511962Q34310417-0C82372F-390A-433F-8CE3-B77E25553703Q34479272-2C000DF9-55D3-46DA-A7AA-FF9EED70E841Q34484872-FA865588-1536-471D-A694-B7BB97560DA2Q34491823-A2323ED5-4015-4B37-AE8A-8C466E07ADFBQ34522481-40A224EC-A7CF-4CC1-8DFD-D2F2173ED63F
P2860
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@ast
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@en
type
label
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@ast
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@en
prefLabel
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@ast
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@en
P2093
P2860
P356
P1476
Chronic hepatitis C virus infe ...... xamination Survey 2003 to 2010
@en
P2093
Geraldine M McQuillan
Jan Drobeniuc
John W Ward
Maxine M Denniston
R Monina Klevens
Ruth B Jiles
Scott D Holmberg
P2860
P304
P356
10.7326/M13-1133
P407
P577
2014-03-01T00:00:00Z